Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

Détails bibliographiques
Auteurs principaux:	Couillard, S, Pavord, I, Heaney, L, Petousi, N, Hinks, T
Format:	Journal article
Langue:	English
Publié:	Wiley 2022

Documents similaires

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
par: Couillard, S, et autres
Publié: (2021)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
par: Couillard, S, et autres
Publié: (2021)

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
par: Couillard, S, et autres
Publié: (2022)

Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
par: Couillard, S, et autres
Publié: (2020)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
par: Rastogi, S, et autres
Publié: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
par: Moran, AM, et autres
Publié: (2020)

Eosinophilic phenotypes of airway disease.
par: Pavord, I
Publié: (2013)

Prognostic value of using FeNO to guide step-down treatment decisions in asthma
par: Wang, K, et autres
Publié: (2018)

Eosinophils in asthma and airway hyperresponsiveness.
par: Brightling, C, et autres
Publié: (2004)

FeNO-based asthma management results in faster improvement of airway hyperresponsiveness
par: Katrine Feldballe Bernholm, et autres
Publié: (2018-10-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
par: Connolly, CM, et autres
Publié: (2017)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
par: Couillard, S, et autres
Publié: (2021)

Exhaled Nitric Oxide (FeNO) as a Non-Invasive Marker of Airway Inflammation
par: Mitsuru Munakata
Publié: (2012-01-01)

The Pitfalls of FeNO Testing
par: Sujoy Khan
Publié: (2013-01-01)

The Lancet COPD Commission: broader questions remain
par: Petousi, N, et autres
Publié: (2023)

The significance of eosinophilic airway inflammation in asthma
par: Pavord, I, et autres
Publié: (2002)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
par: Moran, A, et autres
Publié: (2020)

Toward a predict and prevent approach in obstructive airway diseases
par: Couillard, S, et autres
Publié: (2023)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
par: Brightling, C, et autres
Publié: (2003)

The making of the atomic bomb /
par: 435392 Rhodes, Richard
Publié: (1986)

Prognostic value of FeNO-guided assessment to identify steroid-responsive respiratory symptoms
par: Wang, K, et autres
Publié: (2018)

Association Between FeNO, Total Blood IgE, Peripheral Blood Eosinophil and Inflammatory Cytokines in Partly Controlled Asthma
par: Badar A, et autres
Publié: (2020-10-01)

Current evidence and future research needs for FeNO measurement in respiratory diseases
par: Bjermer, L, et autres
Publié: (2014)

Current evidence and future research needs for FeNO measurement in respiratory diseases.
par: Bjermer, L, et autres
Publié: (2014)

Update on the Role of FeNO in Asthma Management
par: Neveda Murugesan, et autres
Publié: (2023-04-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
par: Brightling, C, et autres
Publié: (2000)

Association of general and abdominal obesity with lung function, FeNO, and blood eosinophils in adult asthmatics: Findings from NHANES 2007–2012
par: Haoyu Zhang, et autres
Publié: (2023-02-01)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
par: Brightling, C, et autres
Publié: (2004)

What is the added value of FeNO as T2 biomarker?
par: María Celeste Marcos, et autres
Publié: (2022-08-01)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
par: Kulkarni, N, et autres
Publié: (2010)

Exposure to organophosphate flame retardants and plasticizers is positively associated with wheeze and FeNO and eosinophil levels among school-aged children: The Hokkaido study
par: Yi Zeng, et autres
Publié: (2023-11-01)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
par: Lavoie, G, et autres
Publié: (2024)

Measuring lung function in airways diseases: current and emerging techniques
par: Petousi, N, et autres
Publié: (2019)

Dark sun : the making of the hydrogen bomb /
par: 435392 Rhodes, Richard
Publié: (1995)

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease
par: Petousi, N, et autres
Publié: (2024)

IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma
par: Jorge Sánchez, et autres
Publié: (2021-03-01)

The change of FeNO is correlated with asthma control and lung function
par: Yanmin Gao, et autres
Publié: (2024-10-01)

FeNO as a biomarker for airway inflammation due to exposure to air pollutants among school children nearby industrial areas in Terengganu
par: Kamaruddin, Anis Syafiqah, et autres
Publié: (2019)

Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) for steroid stewardship in chronic obstructive pulmonary disorder (COPD): A systematic review
par: Aditi Dhawan, et autres
Publié: (2024-09-01)

Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma.
par: I-Chen Chen, et autres
Publié: (2016-01-01)